Lannett gets FDA approval for Codeine Sulfate Tablets
According to IMS, for the year ended April 2014 total sales of Codeine Sulfate Tablets USP 15mg, 30mg and 60mg at Average Wholesale Price (AWP) were about $4.3m.
Genprex has received a notice of allowance from the Canadian Intellectual Property Office (CIPO) for a patent related to the use of its Reqorsa Gene Therapy (quaratusugene ozeplasmid) in combination with either programmed cell death protein 1 (PD-1) or PD-L1 antibodies to treat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).